CAS: 5118-29-6 - Melitracen
Fórmula:C21H25N
InChI:InChI=1S/C21H25N/c1-21(2)19-13-7-5-10-17(19)16(12-9-15-22(3)4)18-11-6-8-14-20(18)21/h5-8,10-14H,9,15H2,1-4H3
Clave InChI:InChIKey=GWWLWDURRGNSRS-UHFFFAOYSA-N
SMILES:C=1C=CC2=C(C1)C(=CCCN(C)C)C=3C=CC=CC3C2(C)C
- Sinónimos:
- 1-Propanamine, 3-(10,10-dimethyl-9(10H)-anthracenylidene)-N,N-dimethyl-
- 3-(10,10-Dimethyl-9(10H)-anthracenylidene)-N,N-dimethyl-1-propanamine
- 9,10-Dihydro-10,10-dimethyl-9-(3-dimethylaminopropylidene)anthracene
- 9-(3-Dimethylaminopropylidene)-10,10-dimethyl-9,10-dihydroanthracene
- 9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene
- 9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene [Italian]
- Adaptol
- Brn 1980107
- Dixeran
- Melitracene
- Ver más sinónimos
- Melitracene [INN-French]
- Melitraceno
- Melitraceno [INN-Spanish]
- Melitracenum
- Melitracenum [INN-Latin]
- N 7001
- N,N,10,10-Tetramethyl-delta(sup 9(10),gamma)-anthracenepropylamine
- N,N-Dimethyl-3-(10,10-dimethyl-9(10H)-anthrylidene)propylamine
- Thymeol
- Trausabun
- U-24973
- delta-(sup 9(10),gamma)-Anthracenepropylamine, N,N,10,10-tetramethyl-
- Δ<sup>9(10</sup><sup>H</sup><sup>),γ</sup>-Anthracenepropylamine, N,N,10,10-tetramethyl-
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Melitracen REF: TM-T20017CAS: 5118-29-6 | - - - | 1.437,00 €~2.364,00 € | Mar 10 Dic 24 | |
Melitracen REF: 3D-FAA11829CAS: 5118-29-6 | Min. 95% | A consultar | Lun 13 Ene 25 |
Melitracen
CAS:5118-29-6
Melitracen is a tricyclic antidepressant.
Fórmula:
C21H25N
Forma y color:
Solid
Peso molecular:
291.43
Ref: TM-T20017
25mg | 1.437,00 € | ||
50mg | 1.872,00 € | ||
100mg | 2.364,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Melitracen
CAS:5118-29-6
Melitracen is a new drug that has been developed to treat inflammatory bowel disease. It …
Fórmula:
C21H25N
Pureza:
Min. 95%
Peso molecular:
291.4 g/mol
Ref: 3D-FAA11829
5g | A consultar | ||
10g | A consultar | ||
25g | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025